IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q3 2016 Holdings

Filed 2016-11-14 | 6 holdings | $130.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Entellus MED IncCOM29363K105$77.4K3,489,53359.4%
Catabasis Pharmaceuticals inCOM14875P107$17.6K2,857,66713.5%
Ocular Therapeutix Inc(OCUL)COM67576A100$13.3K1,932,60710.2%
Transenterix IncCOM NEW89366M201$12.8K7,546,6929.8%
Raptor Pharmaceutical CorpCOM75382F106$8.0K888,1326.1%
Lombard MED IncCOMG55598109$1.2K1,275,7790.9%